Reposting because mods took it down. Probably because they’re long.
This is no more than an absurdly expensive science project that nets 2-3 million quarterly on a whopping 7B market cap. My price target for this is $4-6 by Jan 27.
Technicals look primed for a retest of $12 and lower
P/S 660
Revenue decreasing Y/Y
Insiders haven’t bought their own shares in 3 years, only selling.
Negative operating cash flow increasing 25+% Q/Q